PMID- 36846137 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230228 IS - 1664-2295 (Print) IS - 1664-2295 (Electronic) IS - 1664-2295 (Linking) VI - 14 DP - 2023 TI - Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke. PG - 1083972 LID - 10.3389/fneur.2023.1083972 [doi] LID - 1083972 AB - Arachidonic Acid (AA) is the precursor of cerebrovascular active substances in the human body, and its metabolites are closely associated with the pathogenesis of cerebrovascular diseases. In recent years, the cytochrome P450 (CYP) metabolic pathway of AA has become a research hotspot. Furthermore, the CYP metabolic pathway of AA is regulated by soluble epoxide hydrolase (sEH). 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU) is a novel sEH inhibitor that exerts cerebrovascular protective activity. This article reviews the mechanism of TPPU's protective effect on ischemic stroke disease. CI - Copyright (c) 2023 Huang. FAU - Huang, Pan AU - Huang P AD - Department of Neurology, People's Hospital of Deyang City, Deyang, Sichuan, China. LA - eng PT - Journal Article PT - Review DEP - 20230208 PL - Switzerland TA - Front Neurol JT - Frontiers in neurology JID - 101546899 PMC - PMC9945277 OTO - NOTNLM OT - TPPU OT - arachidonic acid OT - blood-brain barrier OT - ischemia reperfusion OT - ischemic stroke COIS- The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/02/28 06:00 MHDA- 2023/02/28 06:01 PMCR- 2023/02/08 CRDT- 2023/02/27 05:39 PHST- 2022/10/29 00:00 [received] PHST- 2023/01/20 00:00 [accepted] PHST- 2023/02/27 05:39 [entrez] PHST- 2023/02/28 06:00 [pubmed] PHST- 2023/02/28 06:01 [medline] PHST- 2023/02/08 00:00 [pmc-release] AID - 10.3389/fneur.2023.1083972 [doi] PST - epublish SO - Front Neurol. 2023 Feb 8;14:1083972. doi: 10.3389/fneur.2023.1083972. eCollection 2023.